Dentsply International reported $427M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
3M USD 2.46B 398M Mar/2026
Agilent USD 990M 44M Mar/2026
Align Technology USD 736.59M 53M Mar/2026
Bruker USD 379.8M 69.4M Mar/2026
Cardinal Health USD 2.5B 101M Mar/2026
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cooper Companies USD 735.4M 40.2M Mar/2026
CVS Health USD 15.62B 2.06B Mar/2026
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 427M 16M Mar/2026
Henry Schein USD 1.07B 7M Mar/2026
Idexx Laboratories USD 722.74M 64.62M Mar/2026
Illumina USD 721M 38M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
McKesson USD 3.68B 143M Dec/2025
Medtronic USD 6.01B 595M Mar/2026
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Owens Minor USD 272.05M 20.92M Dec/2025
Repligen USD 108.28M 4.45M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Smith & Nephew USD 2.09B 117M Dec/2025
Stryker USD 3.81B 675M Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Veradigm USD 83.44M 3.95M Sep/2022
Waters USD 542M 15.42M Mar/2026
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025
Zoetis USD 1.62B 20M Mar/2026